1296P Neoadjuvant Camrelizumab and Apatinib in Patients with Resectable Non-Small-cell Lung Cancer: One-year Update from a Phase II Trial
ANNALS OF ONCOLOGY(2023)
Key words
Non-Small Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined